These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16536679)

  • 1. Osteoporosis management in a Medicaid population after the Women's Health Initiative study.
    Lee E; Wutoh AK; Xue Z; Hillman JJ; Zuckerman IH
    J Womens Health (Larchmt); 2006 Mar; 15(2):155-61. PubMed ID: 16536679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the Women's Health Initiative on hormone replacement therapy in a Medicaid program.
    Hillman JJ; Zuckerman IH; Lee E
    J Womens Health (Larchmt); 2004 Nov; 13(9):986-92. PubMed ID: 15665655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
    Udell JA; Fischer MA; Brookhart MA; Solomon DH; Choudhry NK
    J Bone Miner Res; 2006 May; 21(5):765-71. PubMed ID: 16734392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why are physicians reluctant to use estrogens for anything--or do they prefer 'PROFOX'?
    Studd J
    Menopause Int; 2009 Jun; 15(2):52-4. PubMed ID: 19465668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis.
    Penning-van Beest FJ; Goettsch WG; Erkens JA; Herings RM
    Clin Ther; 2006 Feb; 28(2):236-42. PubMed ID: 16678644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' and clinicians' attitudes after the Women's Health Initiative study.
    Blümel JE; Castelo-Branco C; Chedraui PA; Binfa L; Dowlani B; Gómez MS; Sarrá S
    Menopause; 2004; 11(1):57-61. PubMed ID: 14716183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribing.
    Lee E; Maneno MK; Wutoh AK; Zuckerman IH
    J Womens Health (Larchmt); 2010 May; 19(5):847-54. PubMed ID: 20459329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of medication use before and after bone densitometry: factors associated with appropriate treatment.
    Solomon DH; Levin E; Helfgott SM
    J Rheumatol; 2000 Jun; 27(6):1496-500. PubMed ID: 10852277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.
    Guay MP; Dragomir A; Pilon D; Moride Y; Perreault S
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):17-27. PubMed ID: 16794994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the women's health initiative on prescription anti-osteoporosis medication utilization.
    Farley JF; Blalock SJ; Cline RR
    Osteoporos Int; 2008 Nov; 19(11):1603-12. PubMed ID: 18373048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar; 151(11):46-7. PubMed ID: 19469206
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
    Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
    J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the Women's Health Initiative study publication on hormone replacement therapy use among women who have undergone BRCA1/2 testing.
    Dorval M; Vallée MH; Plante M; Chiquette J; Gaudet M; Simard J
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):157-60. PubMed ID: 17220345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Curr Med Res Opin; 2006 May; 22(5):919-28. PubMed ID: 16709313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The attitude of gynecologists in São Paulo, Brazil 3 years after the Women's Health Initiative study.
    Lazar F; Costa-Paiva L; Morais SS; Pedro AO; Pinto-Neto AM
    Maturitas; 2007 Feb; 56(2):129-41. PubMed ID: 16901660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between studies and general practice].
    MMW Fortschr Med; 2006 Nov; 148(46):49. PubMed ID: 17615791
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic options: an evidence-based approach to prevention and treatment of osteoporosis.
    Miller E
    Int J Fertil Womens Med; 2003; 48(3):122-6; discussion 137-8. PubMed ID: 12839143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.